This website provides quarterly reports that identify and analyze new risks related to medications and adverse drug events submitted to the Food and Drug Administration (FDA).  The report for the 2nd quarter of 2019 focuses on problems related to methotrexate errors, addictive drugs, and underreporting of adverse drug events. The publication has been discontinued as of December 2019.